Ethyl Acetate

Ethyl Acetate

SCHEMBL278533

CCCCCCC(Cl)Cl.CCOC(C)=O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
LMNA P02545 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ZDHHC7 Q9NXF8 1/20 0.44
FAAH O00519 3/20 0.42
GPR84 Q9NQS5 7/20 0.41
FFAR1 O14842 1/20 0.41
MAPT P10636 2/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL29038293 1.00 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Ethyl Acetate SCHEMBL148560 1.00 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Ethyl Acetate SCHEMBL1268307 1.00 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Ethyl Acetate SCHEMBL8532167 0.98 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Ethyl Acetate SCHEMBL28478460 0.98 ALDH1A1 (0.54) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Heptane SCHEMBL4621147 0.88 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Heptane SCHEMBL17105901 0.87 ALDH1A1 (0.54) ALDH1A1LMNAHSD17B10FAAHMAPT
Heptane SCHEMBL4126646 0.86 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Hexane SCHEMBL8542408 0.86 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10ZDHHC7FAAH
Hexane SCHEMBL133237 0.86 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10ZDHHC7FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 667 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116539778-A Method for measuring concentration of clozapine and quetiapine in blood plasma 石家庄华创医学检验实验室有限公司 2023-08-04 CN claimed
CN-113166140-B CDK8/19 inhibitors 拜奥卡德联合股份公司 2024-06-14 CN disclosed
US-20240182463-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG SHIONOGI & CO., LTD. (JP) 2024-06-06 US disclosed
US-11987579-B2 Niclosamide analogues and therapeutic use thereof DUKE UNIVERSITY (US) 2024-05-21 US disclosed
WO-2024024701-A1 OPTICALLY ANISOTROPIC FILM AND PHASE DIFFERENCE PLATE AGC株式会社 2024-02-01 WO disclosed
CN-117321026-A Method for producing compound, method for producing polymerizable composition, method for producing polymer, method for producing optical isomer, and compound 三菱化学株式会社 2023-12-29 CN disclosed
US-20230357302-A1 TRITERPENE SAPONIN VARIANTS, METHODS OF SYNTHESIS AND USE THEREOF MEMORIAL SLOAN-KETTERING CANCER CENTER 2023-11-09 US disclosed
US-20230286907-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-09-14 US disclosed
CN-116539778-A Method for measuring concentration of clozapine and quetiapine in blood plasma 石家庄华创医学检验实验室有限公司 2023-08-04 CN disclosed
CN-116539778-A Method for measuring concentration of clozapine and quetiapine in blood plasma 石家庄华创医学检验实验室有限公司 2023-08-04 CN disclosed
US-4721791-A 5-amino or substituted amino 1,2,3-triazoles MERCK & CO., INC. (US) 1988-01-26 US disclosed
EP-0227241-A2 Medicinal indole and indazole keto sulphone derivatives ZENECA INC. (US) 1987-07-01 EP disclosed
EP-0205264-A1 Condensed seven-membered heterocyclic compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1986-12-17 EP disclosed
EP-0199543-A2 Heterocyclic amide derivatives ICI AMERICAS INC. (US) 1986-10-29 EP disclosed
US-4524212-A HYPOTENSIVE AGENTS, ANGIOTENSIN INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1985-06-18 US disclosed
US-4440779-A Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO., INC. (US) 1984-04-03 US disclosed
US-4427586-A ANTI-BACTERIAL AGENTS AND ENZYME INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1984-01-24 US disclosed
EP-0068460-A1 Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO. INC. (US) 1983-01-05 EP disclosed
US-4360470-A Process and intermediates for the synthesis of Vitamin D3 metabolites and chenodeoxycholic acid HOFFMANN-LA ROCHE INC. (US) 1982-11-23 US disclosed
EP-0052299-A1 2-Oxoazetidine derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1982-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182463-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG PREP, UNG, DPP4 ALDH1A1 1564/4885LMNA 1238/4885HSD17B10 1241/4885
US-20230357302-A1 TRITERPENE SAPONIN VARIANTS, METHODS OF SYNTHESIS AND USE THEREOF LSS, GALE, CYP4A11 ALDH1A1 4420/4885LMNA 1802/4885HSD17B10 146/4885
US-11987579-B2 Niclosamide analogues and therapeutic use thereof DNER, SFRP1, WNT1 ALDH1A1 1130/4885LMNA 4067/4885HSD17B10 1002/4885
US-20230286907-A1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS TRPV1, SCN2A, SCN10A ALDH1A1 2665/4885LMNA 2874/4885HSD17B10 3173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.